Completed OBSERVATIONAL NCT01266265

Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso® Compared to Other FDA Approved PAH Therapies (Aspire)

A Postmarketing Observational Study to Assess Respiratory Tract Adverse Events in Pulmonary Arterial Hypertension Patients Treated With Tyvaso® (Treprostinil) Inhalation Solution

Sponsor: United Therapeutics

Conditions Pulmonary Arterial Hypertension

Interventions inhaled prostacyclin oral ERA oral PDE5 inhibitors prostacyclin subcutaneous and intravenous prostacyclin

Updated 7 times since 2017 Last updated: Jan 20, 2016 Started: Dec 31, 2010 Primary completion: Dec 31, 2014 Completion: Dec 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Pulmonary Arterial Hypertension, this trial is completed. The trial is conducted by United Therapeutics and has accumulated 7 data snapshots since 2010. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 2 earlier versions

Feb 2017 — Apr 2018 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Dec 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

United Therapeutics

Data source: United Therapeutics

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Akron, United States , Atlanta, United States , Austell, United States , Baltimore, United States , Berkeley, United States , Beverly Hills, United States , Birmingham, United States , Boston, United States , Carmel, United States , Chapel Hill, United States and 57 more locations